AstraZeneca acquires rights to potential COPD treatment in deal valued at up to $402M
November 28, 2022 at 10:54 AM EST
The global licensing deal also includes exclusive rights for other undisclosed inflammatory and respiratory diseases.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Calendar | Directory | Real Estate | Blog | More
|